Envoy Medical, Inc. (NASDAQ:COCHW) Sees Large Decline in Short Interest

Envoy Medical, Inc. (NASDAQ:COCHW) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totaling 32,325 shares, a decline of 54.3% from the August 31st total of 70,744 shares. Based on an average daily volume of 47,859 shares, the short-interest ratio is presently 0.7 days.

Envoy Medical Price Performance

NASDAQ:COCHW traded down $0.01 during trading hours on Wednesday, hitting $0.03. 17,427 shares of the stock traded hands, compared to its average volume of 25,377. The firm has a 50 day moving average price of $0.04 and a 200 day moving average price of $0.05. Envoy Medical has a fifty-two week low of $0.02 and a fifty-two week high of $0.14.

About Envoy Medical

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technology is designed to be implanted beneath the skin, with the goal of providing hearing support without the external components used by many conventional hearing devices.

Its lead product is the Acclaim cochlear implant, a fully implanted device that uses the body’s natural anatomy to capture sound and stimulate the cochlea. The Acclaim is intended for adults with sensorineural hearing loss and has received Breakthrough Device designation from the U.S.